|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 09-01 | Canaccord Genuity Initiates Aclaris Therapeutics at Buy With $10 Price Target | MT |
| 08-06 | Aclaris Therapeutics Gets Fast-Track Designation for Inflammation Treatment Modzatinib | DJ |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1.48% | 1.62% | 20.12x | 4.74x | 7.11x | 14.28x | 16.16x | 68.52B | |
| 0.04% | 0.08% | 32.41x | 6.42x | 9.38x | 45.24x | 29.69x | 62.88B | |
| -.--% | -.--% | -78.84x | 39.45x | 15.22x | -73.41x | -88.35x | 28.13B | |
| -.--% | -.--% | 29.47x | 3.15x | 6.3x | 16.34x | 19.56x | 25.56B | |
| -.--% | -.--% | -14.82x | 1.21x | 5.45x | -6.85x | -5.4x | 24.65B | |
| -.--% | -.--% | 26.99x | 3.18x | 5.06x | 16.84x | 18.97x | 19.81B | |
| 0.3% | 0.17% | 50.73x | 12.62x | 18.74x | 38.02x | 41.06x | 17.69B | |
| -.--% | -.--% | 1267.09x | 16.97x | 36.54x | 797.35x | -261.5x | 14.66B | |
| -.--% | -.--% | 18.02x | 5.55x | 5.37x | 12.54x | 13.29x | 14.45B | |
| -.--% | -.--% | -14.97x | 51.18x | 3374.56x | -17.25x | -14.82x | 13.99B | |
| -.--% | -.--% | -86.57x | 28.13x | 7.93x | -65.69x | -64.3x | 12.63B | |
| -.--% | -.--% | -22.7x | 29.97x | 23.5x | -25.56x | -22.71x | 11.67B | |
| -.--% | 0.01% | -414.06x | 8.36x | 15.18x | 943.07x | -318.3x | 11.16B | |
| -.--% | -.--% | -12.1x | -77.69x | 61.03x | -12.73x | -12.49x | 10.3B | |
| -.--% | -.--% | -7.1x | - | - | -7.35x | -6.8x | 8.86B | |
| -.--% | -.--% | 8.55x | 4.71x | 6.97x | 11.35x | 11.73x | 8.26B | |
| -.--% | -.--% | -29.7x | 7.81x | - | -26.07x | -26.9x | 7.66B | |
| Average | 0.11% | 0.11% | 45.44x | 9.11x | 239.89x | 97.65x | -39.48x | 21.23B | |
| Weighted average by Cap. | 0.3% | 0.33% | 42.45x | 9.59x | 148.95x | 65.79x | -18.90x |
- Stock Market
- Stocks
- ACRS Stock
- Stock
- Sector ACLS THER
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
